HK1166790A1 - Quaternary ammonium salt compound - Google Patents
Quaternary ammonium salt compoundInfo
- Publication number
- HK1166790A1 HK1166790A1 HK12107408.7A HK12107408A HK1166790A1 HK 1166790 A1 HK1166790 A1 HK 1166790A1 HK 12107408 A HK12107408 A HK 12107408A HK 1166790 A1 HK1166790 A1 HK 1166790A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- quaternary ammonium
- ammonium salt
- salt compound
- compound
- quaternary
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009110760 | 2009-04-30 | ||
| PCT/JP2010/057422 WO2010126025A1 (ja) | 2009-04-30 | 2010-04-27 | 四級アンモニウム塩化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1166790A1 true HK1166790A1 (en) | 2012-11-09 |
Family
ID=43032170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12107408.7A HK1166790A1 (en) | 2009-04-30 | 2012-07-27 | Quaternary ammonium salt compound |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9072734B2 (xx) |
| EP (1) | EP2426121A4 (xx) |
| JP (1) | JP5379224B2 (xx) |
| KR (1) | KR20120061061A (xx) |
| CN (1) | CN102459231B (xx) |
| AR (1) | AR078121A1 (xx) |
| AU (1) | AU2010242646A1 (xx) |
| BR (1) | BRPI1014390A2 (xx) |
| CA (1) | CA2760630A1 (xx) |
| HK (1) | HK1166790A1 (xx) |
| IL (1) | IL216015A0 (xx) |
| MX (1) | MX2011011446A (xx) |
| MY (1) | MY155212A (xx) |
| NZ (1) | NZ595810A (xx) |
| SG (1) | SG177468A1 (xx) |
| TW (1) | TWI486343B (xx) |
| WO (1) | WO2010126025A1 (xx) |
| ZA (1) | ZA201108372B (xx) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
| ITRM20110083U1 (it) | 2010-05-13 | 2011-11-14 | De La Cruz Jose Antonio Freire | Piastra per la costruzione di carrelli per aeroplani |
| ME02297B (me) * | 2011-06-10 | 2016-02-20 | Chiesi Farm Spa | Jedinjenja koja imaju aktivnost antagonista muskarinskih receptora i agonist beta2 adrenergičnog receptora |
| EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
| JP6421989B2 (ja) * | 2012-12-06 | 2018-11-14 | チエシ ファルマスティスィ エス．ピー．エー． | ムスカリン受容体アンタゴニストおよびβ２アドレナリン受容体アゴニスト活性を有する化合物 |
| ES2750523T3 (es) * | 2012-12-18 | 2020-03-26 | Almirall Sa | Derivados de ciclohexil y quinuclidinil carbamato que tienen actividades de agonista beta2 adrenérgicos y antagonistas muscarínicos M3 |
| TWI643853B (zh) | 2013-02-27 | 2018-12-11 | 阿爾米雷爾有限公司 | 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類 |
| TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有ｍａｂａ化合物和皮質類固醇之組合 |
| TWI641373B (zh) | 2013-07-25 | 2018-11-21 | 阿爾米雷爾有限公司 | 具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽 |
| JP6588924B2 (ja) * | 2014-04-25 | 2019-10-09 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | ルテニウムの触媒作用によってアニリド類からビフェニルアミン類を製造する方法 |
| TW201617343A (zh) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物 |
| CN104557589A (zh) * | 2014-12-24 | 2015-04-29 | 天津大学 | N-(1，1’-二芳基)取代的酰胺类衍生物的制备方法 |
| TW201702225A (zh) * | 2015-05-14 | 2017-01-16 | Sichuan Haisco Pharmaceutical Co Ltd | 具有β２受體激動及Ｍ受體拮抗活性的含氮雜螺環衍生物及其在醫藥上的用途 |
| TW201704211A (zh) * | 2015-05-14 | 2017-02-01 | Sichuan Haisco Pharmaceutical Co Ltd | 具有β２受體激動及Ｍ受體拮抗活性的聯苯衍生物及其在醫藥上的用途 |
| KR102278197B1 (ko) | 2016-12-14 | 2021-07-15 | 베이징 서우바이 파마슈티컬 컴퍼니 리미티드 | 4차 암모늄염 구조의 이중기능 화합물 |
| CN108854841B (zh) * | 2018-06-25 | 2020-09-29 | 长治学院 | 一种连接基含酯基的吡咯烷类手性Gemini表面活性剂及其制备方法 |
| US11841822B2 (en) | 2019-04-27 | 2023-12-12 | Cambricon Technologies Corporation Limited | Fractal calculating device and method, integrated circuit and board card |
| CN111217746B (zh) * | 2020-03-10 | 2021-09-24 | 佛山市隆信医药科技有限公司 | 一种盐酸丙卡特罗的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3240784A (en) * | 1966-03-15 | Esters of quaternary z-hydroxy methyl piperidinium compounds | ||
| TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| AU2003249294A1 (en) | 2002-07-17 | 2004-02-02 | Long Y. Chiang | Fullerene compounds |
| CN101239971B (zh) * | 2003-02-14 | 2011-07-20 | 施万制药 | 联苯衍生物 |
| PE20040950A1 (es) | 2003-02-14 | 2005-01-01 | Theravance Inc | DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS |
| WO2004089892A2 (en) | 2003-04-01 | 2004-10-21 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 andrenergic receptor agonist and muscarinic receptor antagonist activity |
| WO2004096127A2 (en) | 2003-04-25 | 2004-11-11 | Kos Life Sciences, Inc. | Formation of strong superporous hydrogels |
| ATE435862T1 (de) | 2003-05-28 | 2009-07-15 | Theravance Inc | Azabicycloalkanverbindungen als muscarinrezeptor antagonisten |
| AU2004267007C1 (en) * | 2003-06-03 | 2010-04-29 | Melinta Subsidiary Corp. | Biaryl heterocyclic compounds and methods of making and using the same |
| AR044851A1 (es) * | 2003-06-24 | 2005-10-05 | Novartis Ag | Compuestos heterociclicos, antagonistas del receptor m3 muscarinico |
| TW200534855A (en) | 2004-01-13 | 2005-11-01 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| EP1999107A2 (en) | 2006-03-20 | 2008-12-10 | Pfizer Limited | Amine derivatives |
| GB0702413D0 (en) | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New chemical compounds |
| AU2009211251B2 (en) | 2008-02-06 | 2012-02-02 | Astrazeneca Ab | Compounds |
-
2010
- 2010-04-27 JP JP2011511402A patent/JP5379224B2/ja not_active Expired - Fee Related
- 2010-04-27 SG SG2011097920A patent/SG177468A1/en unknown
- 2010-04-27 KR KR1020117028059A patent/KR20120061061A/ko not_active Application Discontinuation
- 2010-04-27 BR BRPI1014390A patent/BRPI1014390A2/pt not_active IP Right Cessation
- 2010-04-27 CN CN201080029330.3A patent/CN102459231B/zh not_active Expired - Fee Related
- 2010-04-27 MY MYPI2011005166A patent/MY155212A/en unknown
- 2010-04-27 US US13/266,651 patent/US9072734B2/en not_active Expired - Fee Related
- 2010-04-27 AU AU2010242646A patent/AU2010242646A1/en not_active Abandoned
- 2010-04-27 MX MX2011011446A patent/MX2011011446A/es active IP Right Grant
- 2010-04-27 NZ NZ595810A patent/NZ595810A/xx not_active IP Right Cessation
- 2010-04-27 EP EP10769723A patent/EP2426121A4/en not_active Withdrawn
- 2010-04-27 CA CA2760630A patent/CA2760630A1/en active Pending
- 2010-04-27 WO PCT/JP2010/057422 patent/WO2010126025A1/ja active Application Filing
- 2010-04-29 AR ARP100101446A patent/AR078121A1/es unknown
- 2010-04-30 TW TW099113895A patent/TWI486343B/zh not_active IP Right Cessation
-
2011
- 2011-10-27 IL IL216015A patent/IL216015A0/en unknown
- 2011-11-15 ZA ZA2011/08372A patent/ZA201108372B/en unknown
-
2012
- 2012-07-27 HK HK12107408.7A patent/HK1166790A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR078121A1 (es) | 2011-10-19 |
| JPWO2010126025A1 (ja) | 2012-11-01 |
| CA2760630A1 (en) | 2010-11-04 |
| BRPI1014390A2 (pt) | 2016-04-05 |
| CN102459231B (zh) | 2015-04-22 |
| NZ595810A (en) | 2013-05-31 |
| WO2010126025A1 (ja) | 2010-11-04 |
| US9072734B2 (en) | 2015-07-07 |
| IL216015A0 (en) | 2012-01-31 |
| TW201103909A (en) | 2011-02-01 |
| KR20120061061A (ko) | 2012-06-12 |
| EP2426121A1 (en) | 2012-03-07 |
| AU2010242646A1 (en) | 2011-11-03 |
| US20120046467A1 (en) | 2012-02-23 |
| CN102459231A (zh) | 2012-05-16 |
| MY155212A (en) | 2015-09-30 |
| MX2011011446A (es) | 2011-11-18 |
| TWI486343B (zh) | 2015-06-01 |
| JP5379224B2 (ja) | 2013-12-25 |
| SG177468A1 (en) | 2012-02-28 |
| ZA201108372B (en) | 2012-07-25 |
| EP2426121A4 (en) | 2012-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2100007I1 (hu) | Filgotinib vagy sója | |
| HK1166790A1 (en) | Quaternary ammonium salt compound | |
| HUS000511I2 (hu) | Gilteritinib vagy sója | |
| EP2521711A4 (en) | QUARTER AMMONIUM SALT PRODRUGS | |
| PL2430131T3 (pl) | Czwartorzędowe amidowe sole amonowe | |
| HK1188451A1 (zh) | 咪唑並噁嗪化合物或其鹽 | |
| EP2423182A4 (en) | DIACYLETHYLENEDIAMINE COMPOUND | |
| GB0903759D0 (en) | Compound | |
| EP2563790A4 (en) | PROCESS FOR A QUATERNARY AMMONIA SALT | |
| LT2515658T (lt) | Herbicidiniai agentai, turintys flufenaceto | |
| EP2738163A4 (en) | AMIDINE COMPOUND OR SALT THEREOF | |
| GB0914767D0 (en) | Compound | |
| EP2505585A4 (en) | BIS benzoxazinone CONNECTION | |
| EP2609093A4 (en) | SALT CONNECTION | |
| GB0909213D0 (en) | Compound | |
| GB201002911D0 (en) | Compound | |
| PL2456751T3 (pl) | Sposób wytwarzania nienasyconej czwartorzędowej soli amoniowej | |
| GB201017315D0 (en) | Compound | |
| GB0914883D0 (en) | Compound | |
| EP2940059A4 (en) | QUATERNARY AMMONIUM SALT COMPOUND | |
| EP2698371A4 (en) | NEW VERBUNDADDITIONSALZ AGAINST THROMBOCYTES | |
| EP2487178A4 (en) | PYRAZOLOTHIAZOLVERBINDUNG | |
| EP2674419A4 (en) | QUATERNARY AMMONIUM SALT | |
| EP2502926A4 (en) | COMPOUND | |
| GB201007209D0 (en) | Compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190501 |